SEC Filings

Form 10-K
NANOSPHERE INC filed this Form 10-K on 03/11/10
Document Outline
Entire Document (1003.4 KB)
Subdocument 1 - 10-K - FORM 10-K
Page 1 - N/A
Page 2 - UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Page 3 - NANOSPHERE, INC. INDEX
Page 4 - Forward-Looking Statements
Page 5 - N/A
Page 6 - N/A
Page 7 - Our Applications
Page 8 - Genomic Assays
Page 9 - Protein Assays
Page 10 - Connective-tissue.
Page 11 - •
Page 12 - Schematic of Microarray Based Detection Using Nanoparticle Probes
Page 13 - •
Page 14 - Sales and Marketing
Page 15 - 5
Page 16 - Clinical Investigations
Page 17 - Export of Our Products
Page 18 - Item 1A.
Page 19 - We and our customers are subject to various governmental regulations, and we may incur significant e
Page 20 - We may fail to receive positive clinical results from the diagnostic tests currently in development
Page 21 - The adverse capital and credit market conditions could affect our liquidity.
Page 22 - N/A
Page 23 - We have limited experience in sales and marketing and may be unable to successfully commercialize ou
Page 24 - We will need to develop manufacturing capacity by ourselves or with third parties.
Page 25 - We may not be able to manage our anticipated growth, and we may experience constraints or inefficien
Page 26 - Healthcare reform and restrictions on reimbursement may adversely affect our profitability.
Page 27 - If equity research analysts do not publish research or reports about our business or if they issue u
Page 28 - Our 2007 Long-Term Incentive Plan includes an automatic share replenishment, or “evergreen,” provisi
Page 29 - Concentration of ownership among some of our stockholders, including directors and management may li
Page 30 - PART II
Page 31 - Stock Performance Graph
Page 32 - Item 6.
Page 33 - Item 7.
Page 34 - de novo
Page 35 - Financial Operations Overview
Page 36 - Sales, General and Administrative Expenses
Page 37 - Interest Expense
Page 38 - N/A
Page 39 - •
Page 40 - Contractual Obligations and Commitments
Page 41 - Stock-Based Compensation Expense
Page 42 - Item 7A.
Page 43 - Item 8.
Page 44 - REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Page 45 - N/A
Page 46 - Nanosphere, Inc.
Page 47 - N/A
Page 48 - N/A
Page 49 - N/A
Page 50 - N/A
Page 51 - N/A
Page 52 - N/A
Page 53 - N/A
Page 54 - N/A
Page 55 - N/A
Page 56 - N/A
Page 57 - N/A
Page 58 - N/A
Page 59 - N/A
Page 60 - N/A
Page 61 - N/A
Page 62 - Item 9.
Page 63 - N/A
Page 64 - PART III.
Page 65 - PART IV.
Page 66 - Exhibit Number
Page 67 - N/A
Page 68 - SIGNATURES
Subdocument 2 - EX-23.1 - EXHIBIT 23.1
Page 1 - Exhibit 23.1
Subdocument 3 - EX-31.1 - EXHIBIT 31.1
Page 1 - Exhibit 31.1
Subdocument 4 - EX-31.2 - EXHIBIT 31.2
Page 1 - Exhibit 31.2
Subdocument 5 - EX-32.1 - EXHIBIT 32.1
Page 1 - Exhibit 32.1
Subdocument 6 - EX-32.2 - EXHIBIT 32.2
Page 1 - Exhibit 32.2